Search Results

The takeaway is clear: fast clearance does not necessarily mean loss of efficacy  when binding offset

Breakthroughs this week:  Orphan receptor GPRC5B in neurogenesis; Septerna’s pill-based weight-loss strategy

discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss

DR curves shift to the right with no loss of maximal effect.

Once a ligand crosses into this intracellular space, it behaves differently, often much more favorably

novel fluorescent Endothelin-B receptor probes GPCRs in Cardiology, Endocrinology, and Taste GPRASP1 loss-of-function

loop 2 in the β2-adrenergic receptor mediates interactions with G protein and β-arrestin with a biased loss

Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor cross-linked

was significantly diminished iin Gαi KO and Gα_all KO HEK293 cells, however there was only a minor loss HEK293 cells with CRISPR KO of both β-arrestin1 and β-arrestin2 only led to a small but measurable loss

analysis Reviews, GPCRs, and more Parallel evolution of the G protein-coupled receptor GrlG and the loss

operational details, such as misaligned data from diverse GPCR assay types or communication gaps in cross-functional

GPCR Industry News Septerna Announces the Formation of a Cross-Functional Scientific and Drug Discovery

Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress Parker Moss

With rigor, transparency, and cross-disciplinary collaboration, they’re pushing GPCR science toward a

He also underscores the value of developing cross-functional skills — including communication, strategy

Industry News Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim

dive into the Classified GPCR News from April 1st to 7th, 2024 GPCR Activation and Signaling GPRASP1 loss-of-function

Early cross-screening can flag biased phenotypes long before animal studies.

Months of wasted resources, failed translation, and opportunity loss.

This is especially useful in GPCRs, where structural similarity happens often and thus cross-reactivity

GPCRs posses a seven-transmembrane domain architecture, which lets them transduce extracellular signals

through binding to ADGRL1 and activating cAMP/PKA/CREB/BCL2 signaling pathway Deciphering specificity and cross-reactivity

Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.

Postdoc in GPCR mechanosensing   Postdoctoral Position Postdoctoral research position Adhesion GPCRs Loss

Rodriguez, P.J., et al., Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

activation RhoA-mediated G12-G13 signaling maintains muscle stem cell quiescence and prevents stem cell loss

Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss

droplets; novel atypical GPCR-arrestin complexes; Lilly's oral GLP-1, orforglipron, delivers weight loss

Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in

EC₅₀ and Emax uncouple affinity and efficacy, making cross-agonist comparison unreliable. Dr.